Abbott Named One of the Best Companies for Hispanics by Hispanic Business Magazine

AbbottAbbott has been named to Hispanic Business magazine's list of the nation's best companies for Hispanics. Abbott was recognized as one of the magazine's "Diversity Elite 60" companies for its commitment to Hispanic hiring, promotion, marketing, philanthropy and supplier diversity.

"As an innovation-driven company, Abbott relies on the diversity of our people to provide different ideas, perspectives and experience that enable us to translate science into new solutions for patients," said Stephen Fussell, senior vice president, Human Resources, Abbott.

Diversity a Long-Standing Priority for Abbott
Abbott's commitment to diversity starts at the top with the company's Chairman and Chief Executive Officer Miles D. White, who chairs the company's Executive Inclusion Council. The Council oversees the company's diversity and inclusion efforts, monitors the hiring and advancement of women and minorities in management, and supports programs that promote an inclusive work environment for all employees.

Abbott maintains aggressive goals for the recruitment, hiring and retention of women and minorities. Minorities at Abbott make up more than one-quarter (26 percent), and women nearly one-half (47 percent), of Abbott's total U.S. workforce. Abbott has increased the number of minorities in management by 68 percent and the number of women in management by 64 percent over the past five years.

More than 7,700 employees participate in Abbott's employee networks, which play a vital role in building more diverse leadership within Abbott. These include: LA VOICE Network (Hispanic/Latino), Women Leaders in Action, Black Business Network, Asian Cultural Leadership Network, PRIDE Network gay/lesbian) and the Part-Time Network. By focusing on career development, mentoring, informal networking and work-life integration, Abbott's active networks offer leadership and expanded advancement opportunities for women and minorities. Each network is sponsored by a member of senior management who helps align the group's objectives with Abbott's business strategy.

Abbott Widely Recognized as a Premier Employer
In addition to being included in Hispanic Business magazine's "Diversity Elite 60," Abbott has been included on DiversityInc magazine's list of the "Top 50 Companies for Diversity" for four years. The company was named one of the "Top 50 Companies for Black MBAs to Work" by Black MBA magazine, and has been recognized for many years by FORTUNE magazine as one of the "Best Companies for Minorities."

Abbott also has been included in Working Mother magazine's "100 Best Companies for Working Mothers" for the past seven years, has been named one of the "50 Best Places to Launch a Career" by BusinessWeek and was included in the 2008 edition of the Princeton Review's Best Entry-Level Jobs. In addition, Abbott has been recognized by Science and The Scientist magazines as a top employer for scientists, and FORTUNE has named Abbott as one of "America's Most Admired Companies" every year since the list's inception in 1983.

About Abbott
Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs 65,000 people and markets its products in more than 130 countries.

Abbott's news releases and other information are available on the company's Web site at http://www.abbott.com.

Most Popular Now

Bayer to accelerate drug discovery with Google Clo…

Bayer AG and Google Cloud announced a collaboration to drive early drug discovery that will apply Google Cloud's Tensor Processing Units (TPUs), which are custom-develope...

NextPoint Therapeutics announces $80 million Serie…

NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-l...

AstraZeneca to acquire CinCor Pharma to strengthen…

AstraZeneca has entered into a definitive agreement to acquire CinCor Pharma, Inc. (CinCor), a US-based clinical-stage biopharmaceutical company, focused on developing no...

Acquisition of Neogene Therapeutics completed

AstraZeneca has completed the acquisition of Neogene Therapeutics Inc. (Neogene), a global clinical-stage biotechnology company pioneering the discovery, development and ...

Pfizer expands 'An Accord for a Healthier World' p…

Pfizer Inc. (NYSE: PFE) announced that it has significantly expanded its commitment to An Accord for a Healthier World to offer the full portfolio of medicines and vaccin...

500,000 missed out on blood pressure lowering drug…

Nearly half a million people missed out on starting medication to lower their blood pressure during the COVID-19 pandemic, according to research supported by the British ...

Roche announces the European Commission approval o…

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the European Commission (EC) has approved Xofluza® (baloxavir marboxil) in children aged one year and above for the trea...

Study identifies potential new approach for treati…

Targeting iron metabolism in immune system cells may offer a new approach for treating systemic lupus erythematosus (SLE) - the most common form of the chronic autoimmune...

Nanotechnology may improve gene therapy for blindn…

Using nanotechnology that enabled mRNA-based COVID-19 vaccines, a new approach to gene therapy may improve how physicians treat inherited forms of blindness. A collabo...

Modified CRISPR-based enzymes improve the prospect…

Many genetic diseases are caused by diverse mutations spread across an entire gene, and designing genome editing approaches for each patient’s mutation would be impractic...

Discovery of anti-cancer chemistry makes skullcap …

The evolutionary secrets that enable the medicinal herb known as barbed skullcap to produce cancer fighting compounds have been unlocked by a collaboration of UK and Chin...

A soybean protein blocks LDL cholesterol productio…

A protein in soybeans blocks the production of a liver enzyme involved in the metabolism of triglycerides and low-density lipoprotein, scientists found in a recent study...